Product Program year 2024 Source: CMS Open Payments

Relieva Ultirra

Device Rhinology

PDI 10705031200258

Open in the dashboard

General payments

$7,750

146 payments

Research payments

$0

0 payments

Through program year 2024, $7,750 in general payments and $0 in research payments were reported against Relieva Ultirra (Rhinology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $895 8
2023 General $695 16
2022 General $3,328 51
2021 General $2,832 71

Breakdown

Who paid General payments · program years 2021–2024
  1. Acclarent, Inc $7,554 135 payments
  2. Janssen Pharmaceuticals, Inc $83 5 payments
  3. Biosense Webster, Inc. $73 3 payments
  4. Janssen Biotech, Inc. $29 2 payments
  5. DePuy Synthes Sales Inc. $11 1 payment
Top recipients General payments · program year 2024
  1. Dean Klug Otolaryngology · Germantown, TN $181 20% · 3 payments
  2. Kenneth Hsu Otolaryngology · Plano, TX $147 16% · 1 payment
  3. Nimish Patel Otolaryngology · Round Rock, TX $147 16% · 1 payment
  4. Richard Thrasher Otolaryngology · McKinney, TX $147 16% · 1 payment
  5. Jennifer Dang Otolaryngology · Houston, TX $147 16% · 1 payment

The top 5 of 6 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Otolaryngology $895 100% · 6 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Texas $589 66% · 4 recipients
  2. Tennessee $181 20% · 1 recipient
  3. California $125 14% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

146 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record